Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-13

Clinical Trial Update: Treatment of Cholestatic Pruritus With Sertraline [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated sertraline for treatment of cholestatic pruritus in patients with liver disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline (Sertraline)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Pruritus, Liver Cirrhosis, Biliary | Phase 2 | Status: COMPLETED